← FDA Drug Approvals (Drugs@FDA)

LEVOCETIRIZINE DIHYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: US ANTIBIOTICS · Approved 2016-12-20

Drug application

FDA Application #
ANDA204323
Application type
Abbreviated New Drug Application (Generic)
Brand name
LEVOCETIRIZINE DIHYDROCHLORIDE
Generic name
Levocetirizine Dihydrochloride
Active ingredients
LEVOCETIRIZINE DIHYDROCHLORIDE
Dosage form
TABLET
Route
ORAL
Marketing status
Discontinued
Sponsor
US ANTIBIOTICS
First approval
2016-12-20

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown